Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Clover Health Investments ( (CLOV) ) just unveiled an update.
On December 16, 2025, Clover Health Investments announced that CEO Andrew Toy would present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2026, with the presentation webcast available via the company’s website, underscoring Clover’s efforts to showcase its strategy and performance to the investment community. On January 14, 2026, the company reported that its Medicare Advantage PPO membership grew 53% year over year during the latest Annual Election Period, bringing total membership to about 153,000 as of January 1, 2026, driven by disciplined expansion in core markets, strong member retention above 95%, and the continued rollout of its AI-powered Clover Assistant and Home Care offerings; management highlighted improving cohort economics, enhanced Star Ratings, and operating leverage as factors that position Clover for compounding earnings, margin expansion, and a potential first-ever full-year GAAP net income profitability in 2026, reinforcing its competitive standing in Medicare Advantage even as many rivals retrench.
The most recent analyst rating on (CLOV) stock is a Hold with a $2.50 price target. To see the full list of analyst forecasts on Clover Health Investments stock, see the CLOV Stock Forecast page.
Spark’s Take on CLOV Stock
According to Spark, TipRanks’ AI Analyst, CLOV is a Neutral.
The score is held down primarily by inconsistent cash generation and continued GAAP losses despite improving margins and a strong (zero-debt) balance sheet. Technicals also remain bearish with the price below key moving averages. The earnings call adds some support via strong growth and a path toward 2026 profitability, but lowered 2025 profitability guidance and elevated medical costs limit the upside, and valuation lacks support due to negative earnings and no dividend.
To see Spark’s full report on CLOV stock, click here.
More about Clover Health Investments
Clover Health Investments is a physician enablement technology company focused on the U.S. Medicare market, offering PPO and HMO Medicare Advantage plans across several states with a particular emphasis on wide-network, high-choice PPO products. Its model is powered by the Clover Assistant software platform, which aggregates patient data to support clinical decision-making, improve chronic disease management, and deliver affordable, high-quality healthcare primarily to seniors who have historically lacked adequate access.
Average Trading Volume: 6,816,891
Technical Sentiment Signal: Sell
Current Market Cap: $1.36B
See more data about CLOV stock on TipRanks’ Stock Analysis page.